To our providers and patients,

We want you to know that Cicero Diagnostics remains in operation and our labs are accepting and processing samples without any interruption in service during this challenging time. Please know we are committed to provide all results within 10 days of sample receipt.

Our customer service operations are experiencing heavy call volume, so we ask that you send urgent inquiries via email to info@receptivadx.com. We promise to respond within 45 minutes of your email during normal business operations, 9am - 5pm west coast time. Requests for collection kits are being processed without delay and can be expected within 5-6 working days from the date your kit order has been received.

Thank you again for your understanding and the opportunity to serve you.


Christopher Jackson
President, Cicero Diagnostics


75% of women with unexplained infertility will test positive for BCL6

What is ReceptivaDxTM?

ReceptivaDx is a first of its kind test for the detection of inflammation of the uterine lining most commonly associated with endometriosis, a leading cause of infertility and implantation failure.

Women testing positive for ReceptivaDx are 5 times less likely to succeed in IVF than women testing negative.

ReceptivaDxTM (BCL6 Test) Predicts Chances for a Successful Transfer and Successful Pregnancy

Where’s My Nearest Center?

ReceptivaDxTM Center Finder

We are adding new IVF Centers every week to our list of sites where ReceptivaDx testing is offered. If you do not see a center close by, give us a call at (800) 795-5385 as some centers are not currently listed.

ReceptivaDxTM Testing Can Help Make a Difference

Current News, Blogs, and Events

Mon Oct 15, 2018 Event

Last week, ReceptivaDx joined many industry leaders at the American Society for Reproductive Medicine (ASRM)...

The ReceptivaDxTM Test was developed by CiceroDx in conjunction with Pathology Consultants, Inc. of Greenville, SC. Pathology Consultants, Inc. is a laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA). As with other laboratory-developed tests, this testing service has not been cleared or approved by the US FDA or any other federal regulatory agencies. Data have not been submitted to or evaluated by Federal regulatory agencies and the test is not for sale as an In Vitro Diagnostic (IVD) in the US or the EU.

Copyright © 2021 ReceptivaDx™ | All Rights Reserved